Global Systemic Psoriasis Therapeutics Market 2024-2028
Systemic Psoriasis Therapeutics Market 2024-2028
The systemic psoriasis therapeutics market is forecasted to grow by USD 18061.9 mn during 2023-2028, accelerating at a CAGR of 16.2% during the forecast period. The report on the systemic psoriasis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of psoriasis, investments in development of psoriasis therapeutics, and presence of psoriasis therapeutics in pipeline.
Technavio's systemic psoriasis therapeutics market is segmented as below:
By End-user
- Hospitals
- Retail pharmacies
By Product
By Route Of Administration
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the use of phototherapy to treat systemic psoriasis as one of the prime reasons driving the systemic psoriasis therapeutics market growth during the next few years. Also, introduction of systematic oral therapeutics and strategic partnerships among vendors will lead to sizable demand in the market.
The report on the systemic psoriasis therapeutics market covers the following areas:
- Systemic Psoriasis Therapeutics Market sizing
- Systemic Psoriasis Therapeutics Market forecast
- Systemic Psoriasis Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading systemic psoriasis therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bausch Health Companies Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., LEO Pharma AS, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc.. Also, the systemic psoriasis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.